APA (7th ed.) Citation

Malik, P. S., Baral, R., Chugh, B., Dawoud, E., Forde, P., Ghosn, M., . . . Prabhash, K. (2025). Excellence in oncology care (EIOC) consensus guidelines on integrating immunotherapy (IO) in resectable non-small cell lung cancer (NSCLC) for the Middle East and Indian subcontinent. Cancer Research, Statistics & Treatment, 8(4), 298. https://doi.org/10.4103/crst.crst_15_25

Chicago Style (17th ed.) Citation

Malik, Prabhat S., et al. "Excellence in Oncology Care (EIOC) Consensus Guidelines on Integrating Immunotherapy (IO) in Resectable Non-small Cell Lung Cancer (NSCLC) for the Middle East and Indian Subcontinent." Cancer Research, Statistics & Treatment 8, no. 4 (2025): 298. https://doi.org/10.4103/crst.crst_15_25.

MLA (9th ed.) Citation

Malik, Prabhat S., et al. "Excellence in Oncology Care (EIOC) Consensus Guidelines on Integrating Immunotherapy (IO) in Resectable Non-small Cell Lung Cancer (NSCLC) for the Middle East and Indian Subcontinent." Cancer Research, Statistics & Treatment, vol. 8, no. 4, 2025, p. 298, https://doi.org/10.4103/crst.crst_15_25.